Sandeep Parsad

Reizine N, Vokes EE, Liu P, Truong TM, Nanda R, Fleming GF, Catenacci DVT, Pearson AT, Parsad S, Danahey K, van Wijk XMR, Yeo KJ, Ratain MJ, O'Donnell PH. Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial. Ther Adv Med Oncol. 2020 Dec 17;12:1758835920974118. doi: 10.1177/1758835920974118. PMID: 33414846; PMCID: PMC7750903. 

Morgan R, Parsad S, Turaga KK, Eng OS. HIPEC with cisplatin in a patient with a prior hypersensitivity reaction to systemic oxaliplatin. Basic Clin Pharmacol Toxicol. 2020 Jul 5. DOI: 10.1111/bcpt.13464. 

Virani A, Schlei Z, Gleason C, Ackerman M, Parsad S. Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic. Clin Lymphoma Myeloma Leuk. 2020 Sep;20(9):e543-e546. DOI: 10.1016/j.clml.2020.04.012. Epub 2020 May 4. PMID: 32605900 

Parsad S. Pharmacy Operational Considerations with HIPEC Chemotherapy. In The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Ann Surg Oncol. 2020 Jun;27(6):1743-1752. DOI: 10.1245/s10434-020-08325-9. Epub 2020 Apr 13. PMID: 32285276 

Derman BA, Schlei Z, Mullane K, Parsad S, Knoebel RW. Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program. JCO Oncology Practice. 2020. OP. 20.00312 

Yang H, Knoebel RW, Parsad S, Caroll E, Stadler W. Evaluation of prescribing practices of denosumab and zoledronic acid in breast and prostate cancer patients at University of Chicago Medicine. Journal of Clinical Oncology 38, no. 15_suppl. DOI: 10.1200/JCO.2020.38.15_suppl.e24144 

Collins J, Shea K, Parsad S, Plach K, Lee P. The impact of initiating Posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation. J Oncol Pharm Pract 2020 Jan;26(10:5-12. DOI: 10.1177/1078155219833440. Epub2019 Mar 9. PMID: 30854922 

Bergsbaken J, Parsad S. Oncology Patient Management for Adults. In: Hennenfent JA, Pace HA, Eds. Pharmacy Competency Assessment Center. Bethesda, MD. ASHP Learning Center. 2019 

McBride A, Valgus J, Parsad S. Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec. Hosp Pharm. Oct 2018 Parsad S, Nabhan C. Biosimilars. JAMA Oncol. Jun 2018 

Nabhan C, Parsad S, Mato AR, Feinberg BA. Biosimilars in Oncology in the United States: A Review. JAMA Oncol. Feb 2018 

Gyawali B, Parsad S, Feinberg B, Nabhan C. Real-World Evidence and Randomized Studies in the Precision Oncology Era: The Right Balance. JCO Precision Oncology. Oct 2017. 

Parsad S, Ratain MJ. Drug-Drug Interactions with Oral Antineoplastic Agents. JAMA Oncol. Jun 2017 Parsad S, Ratain MJ. Food Effect Studies for Oncology Drug Products. Clin Pharm Ther. Mar 2017. 

Nabhan C, Parsad S, Feinberg B. Positioning CAR-T Therapy into Clinical Pathways for Non- Hodgkin B-Cell Lymphoma and Beyond. J Clin Pathways. Mar 2017 Nabhan C, Parsad S. Ambulatory Oncology Operations: Strategies to Alleviate Complexity. J Natl Compr Canc Netw. Oct 2016 

Vicente M, Al Nahedh M, Parsad S, Knoebel RW , Pisano J, Pettit N. Impact of a Clinical Pathway on Appropriate Empiric Vancomycin Use in Cancer Patients with Febrile Neutropenia. J Oncol Pharm Pract. Sep 2016.

Parsad SD. Developing and implementing processes to support proper use and disposal of personal protective equipment (PPE). In Mansur J, editor: Improving Safe Handling Practices for Hazardous Drugs. Oak Brook, IL: Joint Commission Resources, 2016.